Editorial: Checkpoint Inhibitor-Induced Liver Injury-Time to Abandon CTCAE? Authors' Reply

被引：0
|
作者：
Hountondji, Lina [1 ]
Meunier, Lucy [1 ,2 ,3 ]
机构：
[1] Montpellier Univ Hosp, St Eloi Hosp, Hepatol & Liver Transplantat Dept, Hepatol & Liver Transplantat Unit, Montpellier, France
[2] REFHEPS, Montpellier, France
[3] Montpellier Univ Hosp, St Eloi Hosp, Inst Regenerat Med & Biotherapy IRMB, Hepatol & Liver Transplantat Dept, Montpellier, France
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2024年 / 60卷 / 11-12期
关键词：
D O I：
10.1111/apt.18343
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1623 / 1624
页数：2
相关论文
共 50 条
  • [1] Editorial: Checkpoint Inhibitor-Induced Liver Injury-Time to Abandon CTCAE?
    Torosian, Kelly
    Dave, Shravan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (11-12) : 1621 - 1622
  • [2] Immune Checkpoint Inhibitor-Induced Liver Injury
    Gudd, Cathrin L. C.
    Sheth, Roosey
    Thursz, Mark R.
    Triantafyllou, Evangelos
    Possamai, Lucia A.
    SEMINARS IN LIVER DISEASE, 2023, 43 (04) : 402 - 417
  • [3] Editorial: Safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis-authors' reply
    Dahl, Emilie K.
    Abed, Osama K.
    Kjeldsen, Jens
    Donia, Marco
    Svane, Inge M.
    Dige, Anders
    Agnholt, Jorgen S.
    Bjerrum, Jacob T.
    Seidelin, Jakob B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (01) : 152 - 153
  • [4] Molecular analysis of checkpoint inhibitor-induced liver injury
    Uzun, Sarp
    Zinner, Carl
    Pant, Asmita
    Beenen, Amke
    Heusler, Helene
    Alborelli, Ilaria
    Stalder, Anna
    Sinnreich, Magdalena Filipowicz
    Mertz, Kirsten
    Vosbeck, Jurg
    Terracciano, Luigi Maria
    Heim, Markus
    Laubli, Heinz
    Bernsmeier, Christine
    Matter, Matthias
    JOURNAL OF HEPATOLOGY, 2024, 80 : S291 - S292
  • [5] Diagnostic guide for immune checkpoint inhibitor-induced liver injury
    Ito, Takanori
    Takeuchi, Yasuto
    Mizuno, Kazuyuki
    Imai, Michitaka
    Yoshimaru, Yoko
    Abe, Kazumichi
    Abe, Masanori
    Matsuura, Takanori
    Yokode, Masataka
    Shiokawa, Masahiro
    Kodama, Yuzo
    Komuta, Mina
    Harada, Kenichi
    Tanaka, Atsushi
    HEPATOLOGY RESEARCH, 2024, 54 (08) : 719 - 726
  • [6] Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury
    Hountondji, Lina
    Faure, Stephanie
    Palassin, Pascale
    Viel, PhilineWitkowski Durand
    Dupuy, Marie
    Larrey, Dominique
    Lamoureux, Anouck
    Pureur, Dimitri
    Coustal, Cyril
    Lesage, Candice
    Assenat, Eric
    Riviere, Benjamin
    Faillie, Jean-Luc
    Quantin, Xavier
    Maria, Alexandre
    Pageaux, Georges-Philippe
    Meunier, Lucy
    JOURNAL OF HEPATOLOGY, 2024, 80 : S115 - S116
  • [7] Editorial: Corticosteroids for severe checkpoint inhibitor-induced liver injury-Not one size fits all?
    Cunningham, Morven
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (07) : 905 - 906
  • [8] Editorial: Decoding checkpoint inhibitor-induced endocrinopathies
    Burnett, Deborah L.
    Barnet, Megan B.
    Samaras, Katherine
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [9] Drug-Induced Liver Injury and Immune Checkpoint Inhibitor-Induced Hepatitis
    Bartl S.
    Dinkhauser P.
    Hofer H.
    Journal für Gastroenterologische und Hepatologische Erkrankungen, 2021, 19 (2) : 34 - 43
  • [10] Biologic and Checkpoint Inhibitor-Induced Liver Injury: A Systematic Literature Review
    Shah, Parth
    Sundaram, Vinay
    Bjornsson, Einar
    HEPATOLOGY COMMUNICATIONS, 2020, 4 (02) : 172 - 184
12345